Randomized phase II study of docetaxel vs Paclitaxel for patients with advanced or recurrent esophageal cancer who previously received fluoropyrimidine and platinum-based chemotherapy (OGSG1201)

Sachiko Yamamoto, Takayuki Kii, Kazumasa Fujitani, Jin Matsuyama, Hiroki Hara, Shugo Ueda, Shunji Endo, Tatsuya Okuno, Kazuhiko Nakagawa, Ryohei Kawabata, Daisuke Sakai, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh, Toshimasa Tsujinaka, Hiroshi Furukawa ESMO2014, Madrid, Spain, 26-30 Sep 2014